Stay updated on Adjunctive Troriluzule in OCD Clinical Trial
Sign up to get notified when there's something new on the Adjunctive Troriluzule in OCD Clinical Trial page.

Latest updates to the Adjunctive Troriluzule in OCD Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check21 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4 and changed the date from 2025-03-25 to 2025-01-14.SummaryDifference1.0%
- Check29 days agoNo Change Detected
- Check65 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference5%
- Check79 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check87 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
- Check101 days agoChange DetectedThe website has updated its status to 'Active, not recruiting' as of January 14, 2025, following the removal of the 'Recruiting' status from April 19, 2024.SummaryDifference2%
Stay in the know with updates to Adjunctive Troriluzule in OCD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjunctive Troriluzule in OCD Clinical Trial page.